EN PL

EMA: Draft guideline on the evaluation of medicinal products for the treatment of irritable bowel syndrome

25.07.2013
This guideline intends to address the EU regulatory position in the main topics of clinical development of new medicinal products in the treatment of patients with Irritable Bowel Syndrome (IBS).